Data / Form D filings / CARDIODX INC
CARDIODX INC: Form D filings
CARDIODX INC, a biotechnology company in Redwood City, CA, filed 7 Form D notices with the SEC between 2010 and 2017. The latest, on January 18, 2017, reports $18.1 million sold of a $41.8 million offering to 7 investors.
Find out what CARDIODX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 600 SAGINAW DR., Redwood City, CA, 94063
- Phone
- (650) 475-2788
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1304909
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 18, 2017 | New notice | $41,753,500 | $18,125,400 | $23,628,100 | 7 | Jan 5, 2017 | sec.gov |
| Feb 22, 2016 | Amendment | $25,500,912 | $12,369,483 | $13,131,429 | 15 | Jun 17, 2015 | sec.gov |
| Jun 30, 2015 | New notice | $5,000,008 | $5,000,008 | $0 | 13 | Jun 17, 2015 | sec.gov |
| Jul 24, 2014 | New notice | $24,999,996 | $20,983,348 | $4,016,648 | 14 | Jul 19, 2014 | sec.gov |
| Aug 31, 2012 | New notice | $58,018,795 | $30,509,397 | $27,509,398 | 28 | Aug 16, 2012 | sec.gov |
| Mar 2, 2011 | New notice | $78,325,737 | $57,491,448 | $20,834,289 | 17 | Feb 17, 2011 | sec.gov |
| May 14, 2010 | New notice | $44,536,736 | $34,564,513 | $9,972,223 | 16 | May 6, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hongjie G. Hu | Director | |
| Mark G. Monane | Executive Officer | |
| Patrick G. Enright | Director | |
| Ajit G. Singh | Director | |
| David L. Levison | Director | |
| Tim G. Henn | Executive Officer | |
| Khushro F. Mehta | Executive Officer, Director | |
| Susan G. Daniels | Executive Officer | |
| Jim G. Wingrove | Executive Officer | |
| Duane G. Williams | Executive Officer |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Jan 16, 2017 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CARDIODX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.